Background Although the three vaccines against coronavirus disease 2019 (Covid-19) that
have received emergency use authorization in the United States are highly effective, …

The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
exhibits reduced susceptibility to vaccine-induced neutralizing antibodies, requiring a boost to …

Background Poor neurodevelopmental outcomes and recurrences of cutaneous lesions remain
unacceptably frequent among survivors of neonatal herpes simplex virus (HSV) disease. …

Herpes simplex virus (HSV) types 1 and 2 are ubiquitous organisms that cause infections in
human populations throughout the world. The clinical manifestations of HSV infections are …

ContextA high priority in vaccine research is the development of influenza vaccines that do
not use embryonated eggs as the substrate for vaccine production.ObjectiveTo determine the …

Background. No licensed cholera vaccine is presently available in the United States.
Cholera vaccines available in other countries require 2 spaced doses. A single-dose cholera …

Background: While Coronavirus disease 2019 (Covid-19) vaccines are highly effective,
breakthrough infections are occurring. Booster vaccinations have recently received emergency …

As part of a multicenter study evaluating homologous and heterologous COVID-19 booster
vaccines, we assessed the magnitude, breadth, and short-term durability of binding and …

Background: Rotavirus is a major cause of gastroenteritis in children worldwide and is
estimated to be responsible for more than 500,000 physician visits, 50,000 hospitalizations and …

BACKGROUND: A replication incompetent herpes virus lacking the glycoprotein H gene has
been developed as a potential therapeutic vaccine for genital herpes. GOAL: To determine …